The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Carcinoma, Transitional Cell; Cisplatin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized
PubMed ID
37369081
PubMed Central ID
PMC10852367
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal